Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 0 | ||||
Sells | 6 | -425K | 100% | $17.88 | -$7.59M |
Net | -6 | -425K | -100% | -$7.59M |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Avoro Capital Advisors LLC | 10%+ Owner | $10M | Sep 12, 2023 | ||
Dennis D. Kim | Chief Medical Officer | $474K | Apr 13, 2023 | ||
Robert James Wills | Director | $0 | Mar 22, 2024 | ||
Kurt Von Emster | Director | $0 | -$250K | -100% | Mar 22, 2024 |
Janet Dorling | Director | $0 | -$562K | -100% | Mar 22, 2024 |
Harish Shantharam | Chief Financial Officer | $0 | Mar 22, 2024 | ||
Sujal Shah | Chief Executive Officer, Director | $0 | -$3.25M | -100% | Mar 22, 2024 |
Charles McWherter | President of R&D | $0 | -$1.55M | -100% | Mar 22, 2024 |
Paul Quinlan | General Counsel | $0 | -$1.28M | -100% | Mar 22, 2024 |
Klara Dickinson | Chief Regulatory Officer | $0 | Mar 22, 2024 | ||
Caroline M. Loewy | Director | Mar 22, 2024 | |||
Thomas G. Wiggans | Director | Mar 22, 2024 | |||
Eric Lefebvre | Director | Mar 22, 2024 | |||
Daniel Menold | Vice President, Finance | -$708K | Jan 16, 2024 | ||
Lewis J. Stuart | Chief Commercial Officer | Jan 25, 2023 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|